Citatuzumab bogatox

Cat. No.: IBDI-431752

Citatuzumab bogatox (VB6-845) is recombinant immunotoxin that composed of Fab fragment of humanized antibody targeting EpCAM and a modified cytotoxin bouganin. Citatuzumab bogatox binds to and selectively induces apoptosis in EpCAM-positive cell lines and shows good activity in EpCAM-positive human tumour xenograft models.

Product Details

Target	Apoptosis
Synonyms	VB6-845, Anti-Human EpCAM Recombinant Antibody Fab Fragment, 17-1A
SMILES	[Citatuzumab bogatox]

Storage & Handling

Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.